NuCana (NCNA) Interest & Investment Income (2017 - 2025)

NuCana's (NCNA) quarterly Interest & Investment Income came in at $287414.1 in Q3 2025, up 178.16% year-on-year from $103325.1 in Q3 2024, and up 259.08% quarter-over-quarter from $80042.7 in Q2 2025.

NuCana (NCNA) Interest & Investment Income (2017 - 2025) Analysis & Trends

NuCana has disclosed Interest & Investment Income across 9 years of filings, most recently posting $287414.1 for Q3 2025.

  • Interest & Investment Income for Q3 2025 came in at $287414.1, up 178.16% year-over-year; the trailing twelve-month figure through Sep 2025 was $287414.1 (up 178.16% YoY), and the FY2025 annual result was $508945.0, up 11.22% from the prior year.
  • Interest & Investment Income came in at $287414.1 for Q3 2025 at NuCana, up from $80042.7 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $781544.5 in Q3 2023 to a low of -$581883.9 in Q2 2023.
  • The 5-year median for Interest & Investment Income is $33094.1 (2021), against an average of $38009.9.
  • Across the five-year window, Interest & Investment Income soared 301.06% in 2022 and sank 712.44% in 2023, its largest moves.
  • NuCana's Interest & Investment Income stood at $111665.3 in 2021, then surged by 301.06% to $447848.4 in 2022, then jumped by 74.51% to $781544.5 in 2023, then slumped by 147.05% to -$367701.9 in 2024, then jumped by 178.16% to $287414.1 in 2025.
  • The last three Interest & Investment Income figures came in at $287414.1 (Q3 2025), $80042.7 (Q2 2025), and $31487.5 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 597,319.59
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 305,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 114.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - -14.79 Mn
10 NuCana 29.13 Bn 29.13 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 287,414.14
Jun 30, 2025 80,042.74
Mar 31, 2025 31,487.51
Sep 30, 2024 -367,701.95
Jun 30, 2024 266,328.58
Mar 31, 2024 159,833.29
Sep 30, 2023 781,544.52
Jun 30, 2023 -581,883.87
Mar 31, 2023 -348,851.23
Sep 30, 2022 447,848.35
Jun 30, 2022 -205,268.22
Mar 31, 2022 -42,938.74
Sep 30, 2021 111,665.25
Jun 30, 2021 -82,465.97
Mar 31, 2021 33,094.10
Sep 30, 2020 301,977.65
Jun 30, 2020 258,272.68
Mar 31, 2020 -184,588.56
Sep 30, 2019 -1.07 Mn
Jun 30, 2019 -792,368.57